Peripheral T Cell Lymphoma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CCCC | F | C4 Therapeutics, Inc. | 2.04 | |
KURA | B | Kura Oncology, Inc. | -3.77 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Peripheral T Cell Lymphoma stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.46 | |
PTH | B | Invesco DWA Healthcare Momentum ETF | 1.4 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 1.34 | |
XBI | B | SPDR S&P Biotech ETF | 1.24 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.06 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 10 | CCCC | C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors |
Related Industries:
Biotechnology
- Peripheral T Cell Lymphoma
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles